首页> 外文期刊>Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society >Timing of Liver Transplantation FollowingTransjugular Intrahepatic PortosystemicShunt in Patients with Budd-ChiariSyndrome
【24h】

Timing of Liver Transplantation FollowingTransjugular Intrahepatic PortosystemicShunt in Patients with Budd-ChiariSyndrome

机译:Budd-Chiari综合征患者经颈静脉肝内门静脉分流术后肝移植的时机

获取原文
获取原文并翻译 | 示例
           

摘要

Background Aims: Budd-Chiari syndrome (BCS) is a rare and life-threatening disorder secondary to he-patic venous outflow obstruction. Small series of BCSpatients indicate that transjugular intrahepatic porto-systemic shunt (TIPS) may be useful. However, theinfluence of TIPS on patient survival and factors thatpredict the outcome of TIPS in BCS patients remainunknown. Methods: One hundred twenty-four consec-utive BCS patients treated with TIPS in 6 Europeancenters between July 1993 and March 2006 were fol-lowed until death, orthotopic liver transplantation(OLT), or last clinical evaluation. Results: Prior totreatment with TIPS, BCS patients had a high Model ofEnd Stage Liver Disease and high Rotterdam BCSprognostic index (98% of patients at intermediate orhigh risk) indicating severity of liver dysfunction.However, 1- and 5-year OLT-free survival were 88% and78%, respectively. In the high-risk patients, 5-yearOLT-free survival was much better than that estimatedby the Rotterdam BCS index (71% vs 42%, respec-tively). In the whole population, bilirubin, age, andinternational normalized ratio for prothrombin timeindependently predicted 1-year OLT-free survival. Aprognostic score with a good discriminative capacity(area under the curve, 0.86) was developed from thesevariables. Seven out of 8 patients with a score >7 diedor underwent transplantation vs 5 out of 114 patientswith a score <7. Conclusions: Long-term outcome forpatients with severe BCS treated with TIPS is excellenteven in high-risk patients, suggesting that TIPS mayimprove survival. Furthermore, we identified a smallsubgroup of BCS patients with poor prognosis despiteTIPS who might benefit from early OLT.
机译:背景目的:Budd-Chiari综合征(BCS)是继发于肝静脉流出道阻塞的一种罕见且危及生命的疾病。 BCS患者的小系列研究表明,经颈静脉肝内门-全身分流术(TIPS)可能有用。然而,尚不清楚TIPS对患者生存的影响以及预测BCS患者TIPS结局的因素。方法:对1993年7月至2006年3月在欧洲6个中心接受TIPS治疗的124例连续BCS患者进行随访,直至死亡,原位肝移植(OLT)或最后一次临床评估。结果:在接受TIPS治疗之前,BCS患者的终末期肝病模型较高,鹿特丹BCS的预后指数较高(98%处于中危或高危患者),表明肝功能障碍的严重程度,但是无OLT生存期为1年和5年。分别是88%和78%。在高危患者中,无OLT的5年生存率比鹿特丹BCS指数估计的要好得多(分别为71%和42%)。在整个人群中,胆红素,年龄和凝血酶原时间的国际标准化比率独立地预测了1年无OLT生存期。从这些变量中得出了具有良好判别能力的预后评分(曲线下面积为0.86)。得分> 7的死者中有8名患者中有7名接受了移植,而得分<7的114名患者中有5名接受了移植。结论:在高危患者中,接受TIPS治疗的重度BCS患者的长期预后极好,这表明TIPS可以改善生存率。此外,我们确定了一小部分预后不良的BCS患者,尽管TIPS可能从早期OLT中受益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号